Clinical Trial Update: Armodafinil (Nuvigil), Postoperative Recovery of OSA (Obstructive Sleep Apnea) and Obese Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating armodafinil (Nuvigil) for postoperative recovery in obese patients with obstructive sleep apnea has completed with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Obstructive Sleep Apnea
• Premature Recovery From Anesthesia

Drugs mentioned

• Armodafinil (armodafinil)
• NUVIGIL (armodafinil)

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Obesity, Premature Recovery From Anesthesia | Phase 3 | Status: COMPLETED | Results posted: 2016-03-23